A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
Open Access
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 262 (30) , 14663-14671
- https://doi.org/10.1016/s0021-9258(18)47847-7
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects.Journal of Clinical Investigation, 1987
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signallingCell, 1985
- Human insulin receptor and its relationship to the tyrosine kinase family of oncogenesNature, 1985
- Modelling the ATP‐binding site of oncogene products, the epidermal growth factor receptor and related proteinsFEBS Letters, 1984
- In VitroDeletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone.DNA, 1983
- Quantitative ultrastructural analysis of receptor‐mediated insulin uptake into adipocytesJournal of Cellular Physiology, 1983
- Coated vesicles participate in the receptor-mediated endocytosis of insulin.The Journal of cell biology, 1983
- Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequencesNature, 1981
- Entry of Insulin Into Human Cultured Lymphocytes: Electron Microscope Autoradiographic AnalysisScience, 1978